First-pass extracted concept

Drosophila melanogaster epilepsy model

Candidate: concept label1 source documents4 linked claims

Jump to explainers Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Extracted Explainers

What the tool is doing

This review presents Drosophila as an in vivo model system for studying genetic epilepsies and their functional consequences. It is positioned as a scalable organism for variant interpretation and therapeutic exploration.

Source 1DOI PubMed

Resources required

Use of this model requires fly genetics and access to orthologous Drosophila genes corresponding to human epilepsy genes. The abstract also implies phenotyping and imaging capabilities are needed for downstream analysis.

Source 1DOI PubMed

What problem it solves

It helps address the challenge of interpreting many newly discovered epilepsy-associated variants in vivo. It also offers a more scalable alternative to rodent model generation.

Source 1DOI PubMed

What it does not solve

The abstract does not claim that Drosophila fully replaces rodent or human studies. It also does not specify that every human epilepsy mechanism can be modeled in flies.

Source 1DOI PubMed

Alternatives

Rodent models are explicitly contrasted as important but laborious, expensive, and time-consuming alternatives.

Source 1DOI PubMed

Evidence Snippets

The fruit fly Drosophila melanogaster has been used as a model organism in epilepsy research since the discovery of "bang-sensitive" mutants more than half a century ago.

Evidence 1Source 1DOI PubMedprovenance

Supporting Sources

Source 1review2023Frontiers in Molecular NeuroscienceDOI PubMed

1 evidence snippet 4 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1comparative modelingsupports2023Source 1DOI PubMed

Rodent models have significantly contributed to understanding genetic epilepsies, but their establishment is laborious, expensive, and time-consuming.

Quoted textsource-backed

In the last decades, rodent models have significantly contributed to our understanding of genetic epilepsies but their establishment is laborious, expensive, and time-consuming.

Claim 2model utilitysupports2023Source 1DOI PubMed

Drosophila melanogaster is a versatile in vivo model organism for studying genetic epilepsies.

Quoted textsource-backed

Here, we review Drosophila as a versatile model organism to study genetic epilepsies

Claim 3orthology coveragesupports2023Source 1DOI PubMed

The review states that 81% of human epilepsy genes have an orthologous gene in Drosophila.

Quoted textsource-backed

especially as 81% of human epilepsy genes have an orthologous gene in Drosophila

Claim 4screening capabilitysupports2023Source 1DOI PubMed

Variant-carrying flies can be screened for phenotypic and behavioral abnormalities, seizure-threshold shifts, and responses to anti-seizure medications and other substances.

Quoted textsource-backed

These flies can be screened for phenotypic and behavioral abnormalities, shifting of seizure thresholds, and response to anti-seizure medications and other substances.